These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 36274116)

  • 1. Targeting the DENV NS2B-NS3 protease with active antiviral phytocompounds: structure-based virtual screening, molecular docking and molecular dynamics simulation studies.
    Purohit P; Sahoo S; Panda M; Sahoo PS; Meher BR
    J Mol Model; 2022 Oct; 28(11):365. PubMed ID: 36274116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
    Dwivedi VD; Tripathi IP; Mishra SK
    J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Ganoderma lucidum triterpenoids as potential inhibitors against Dengue virus NS2B-NS3 protease.
    Bharadwaj S; Lee KE; Dwivedi VD; Yadava U; Panwar A; Lucas SJ; Pandey A; Kang SG
    Sci Rep; 2019 Dec; 9(1):19059. PubMed ID: 31836806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of antiviral molecules for dengue: In silico search and biological evaluation.
    Cabarcas-Montalvo M; Maldonado-Rojas W; Montes-Grajales D; Bertel-Sevilla A; Wagner-Döbler I; Sztajer H; Reck M; Flechas-Alarcon M; Ocazionez R; Olivero-Verbel J
    Eur J Med Chem; 2016 Mar; 110():87-97. PubMed ID: 26807547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytochemical Compound Screening to Identify Novel Small Molecules against Dengue Virus: A Docking and Dynamics Study.
    Shimu MSS; Mahmud S; Tallei TE; Sami SA; Adam AA; Acharjee UK; Paul GK; Emran TB; Zaman S; Uddin MS; Saleh MA; Alshehri S; Ghoneim MM; Alruwali M; Obaidullah AJ; Jui NR; Kim J; Kim B
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lead Optimization Studies Towards Finding NS2B/NS3 Protease Targetspecific Inhibitors as Potential Anti-dengue Drug-like Compounds.
    Gurusamy M; Abdul JF
    Curr Drug Discov Technol; 2019; 16(3):307-314. PubMed ID: 29984660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and docking studies of peptide inhibitors as potential antiviral drugs for dengue virus ns2b/ns3 protease.
    Velmurugan D; Mythily U; Rao K
    Protein Pept Lett; 2014; 21(8):815-27. PubMed ID: 23855663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D-QSAR pharmacophore-based virtual screening, molecular docking and molecular dynamics simulation toward identifying lead compounds for NS2B-NS3 protease inhibitors.
    Luo PH; Zhang XR; Huang L; Yuan L; Zhou XZ; Gao X; Li LS
    J Recept Signal Transduct Res; 2017 Oct; 37(5):481-492. PubMed ID: 28758854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of highly potent DENV NS2B-NS3 covalent inhibitors containing a phenoxymethylphenyl residue.
    Cheng J; Feng S; Zhang Y; Ding T; Jiang H; Zhang Z; Wang J; Wang X; Cheng M
    Biochem Biophys Res Commun; 2022 Oct; 627():214-219. PubMed ID: 36058105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure activity relationship (SAR) and quantitative structure activity relationship (QSAR) studies showed plant flavonoids as potential inhibitors of dengue NS2B-NS3 protease.
    Sarwar MW; Riaz A; Dilshad SMR; Al-Qahtani A; Nawaz-Ul-Rehman MS; Mubin M
    BMC Struct Biol; 2018 Apr; 18(1):6. PubMed ID: 29673347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.
    Wu DW; Mao F; Ye Y; Li J; Xu CL; Luo XM; Chen J; Shen X
    Acta Pharmacol Sin; 2015 Sep; 36(9):1126-36. PubMed ID: 26279156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling.
    Hariono M; Choi SB; Roslim RF; Nawi MS; Tan ML; Kamarulzaman EE; Mohamed N; Yusof R; Othman S; Abd Rahman N; Othman R; Wahab HA
    PLoS One; 2019; 14(1):e0210869. PubMed ID: 30677071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-guided screening of chemical database to identify NS3-NS2B inhibitors for effective therapeutic application in dengue infection.
    Bhowmick S; Alissa SA; Wabaidur SM; Chikhale RV; Islam MA
    J Mol Recognit; 2020 Jul; 33(7):e2838. PubMed ID: 32060998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in natural products as potential inhibitors of dengue virus with a special emphasis on NS2b/NS3 protease.
    Saqallah FG; Abbas MA; Wahab HA
    Phytochemistry; 2022 Oct; 202():113362. PubMed ID: 35948138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral phytochemicals as potent inhibitors against NS3 protease of dengue virus.
    Rahman MM; Biswas S; Islam KJ; Paul AS; Mahato SK; Ali MA; Halim MA
    Comput Biol Med; 2021 Jul; 134():104492. PubMed ID: 34022487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-dengue infectivity evaluation of bioflavonoid from
    Dwivedi VD; Bharadwaj S; Afroz S; Khan N; Ansari MA; Yadava U; Tripathi RC; Tripathi IP; Mishra SK; Kang SG
    J Biomol Struct Dyn; 2021 Mar; 39(4):1417-1430. PubMed ID: 32107969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual screening of eighteen million compounds against dengue virus: Combined molecular docking and molecular dynamics simulations study.
    Mirza SB; Salmas RE; Fatmi MQ; Durdagi S
    J Mol Graph Model; 2016 May; 66():99-107. PubMed ID: 27054972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Computational Approach Applied to the Study of Potential Allosteric Inhibitors Protease NS2B/NS3 from Dengue Virus.
    Costa RAD; Rocha JAPD; Pinheiro AS; Costa ADSSD; Rocha ECMD; Silva RC; Gonçalves ADS; Santos CBR; Brasil DDSB
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-guided Discovery of a Novel Non-peptide Inhibitor of Dengue Virus NS2B-NS3 Protease.
    Li L; Basavannacharya C; Chan KW; Shang L; Vasudevan SG; Yin Z
    Chem Biol Drug Des; 2015 Sep; 86(3):255-64. PubMed ID: 25533891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.
    Takagi Y; Matsui K; Nobori H; Maeda H; Sato A; Kurosu T; Orba Y; Sawa H; Hattori K; Higashino K; Numata Y; Yoshida Y
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3586-3590. PubMed ID: 28539222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.